-- Analyses suggest the B-cell-depleting mechanism of UPLIZNA did not interfere with important immune activity, including COVID-19 infection defenses and antibody levels from childhood vaccines -- ...

Researchers have identified critical steps leading to myelin destruction in neuromyelitis optica (NMO), a debilitating neurological disease that is commonly misdiagnosed as multiple sclerosis. The ...

Autoimmune diseases cannot currently be cured, only treated, and this is also true for neuromyelitis optica spectrum disorder, which affects the central nervous system. A Kobe University study of how ...

Neuromyelitis optica spectrum disorder (NMOSD), an inflammatory disease of the central nervous system, manifests as optic neuritis, myelitis, and certain brain and brainstem syndromes. Recent ...

Please provide your email address to receive an email when new articles are posted on . The FDA has announced approval of Soliris injection for treatment of neuromyelitis optica spectrum disorder in ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...

A curative treatment for NMOSD does not currently exist. The main treatment goals are remission, long-term stabilization of disease course by means of relapse prevention and residual symptom relief.

Please provide your email address to receive an email when new articles are posted on . Two new studies have shown promising data supporting the use of eculizumab or satralizumab to significantly ...

Enspryng is a new treatment approved for both adults and adolescents with AQP4-IgG seropositive NMOSD in the EU. It is the first treatment approved in the EU for adolescents from 12 years of age with ...

Autoimmune diseases are the molecular equivalent of "friendly fire": the body attacks itself instead of harmful invaders. Now, researchers from Japan have found that interrupting the complex interplay ...

A nonpathogenic monoclonal antibody might hold the key to successful treatment of neuromyelitis optica (NMO)—an autoimmune demyelinating disease characterized by lesions in the optic nerve and spinal ...